Previous Article Next Article
Expert Pitch

Ebola Vaccines Expert Available

Released: 6-Aug-2014 11:00 AM EDT
Source Newsroom: Thomas Jefferson University
Add to Favorites
Contact Information

Available for logged-in reporters only

Dr. Matthias Schnell, Director of the Jefferson Vaccine Center at Thomas Jefferson University is co-developing a broad-acting Ebola vaccine together with the National Institutes of Health (NIH). The team has already created the vaccine construct, and are in the process of manufacturing it for human administration. Dr. Schnell has also applied for grants to develop large quantities of serum for the treatment of already infected Ebola patients. Dr. Schnell is currently abroad, but available for comment.

Promote your organization’s experts with Expert Pitch.
Reporters: follow @Expert_Pitch to receive instant updates via Twitter
Looking for a different expert? Reporters can submit an
Expert Query.